Learn More
Cayman Chemical KSL128114trIfluoroacetAT 10mg

Supplier: Cayman Chemical 3698410 MG
A peptide syntenin inhibitor (Ki = 300 nM); reduces the percent viability of A2058 melanoma and patient-derived GBM cells in a concentration-dependent manner; increases animal survival time in a PDX mouse model of GBM using patient-derived GBM cells co-cultured with KSL-128114 prior to intracranial implantation at 50 µM
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.